Bending the Cost Curve: A Unique Collaboration Between Radiation Oncologists and Blue Cross Blue Shield of Massachusetts to Optimize the Use of Advanced Technology-Reference-Cited by-同舟云学术

Bending the Cost Curve: A Unique Collaboration Between Radiation Oncologists and Blue Cross Blue Shield of Massachusetts to Optimize the Use of Advanced Technology

Published:2014-09 Issue:5 Volume:10 Page:e321-e327
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Steingisser Lee¹,Acker Brian¹,Berman Stuart¹,Brenner Mark J.¹,Bornstein Bruce A.¹,Busse Paul¹,FitzGerald Thomas J.¹,Jacobson Joseph O.¹,Jekowsky Eliot¹,Kachnic Lisa A.¹,Mamon Harvey¹,McKee Andrea¹,Shulman Lawrence N.¹,Stevenson Mary Ann¹,Wazer David¹,Fallon John A.¹

Affiliation:

1. Blue Cross Blue Shield of Massachusetts; Beth Israel Deaconess Medical Center; Massachusetts General Hospital-Harvard Medical School; Brigham and Women's Hospital and Dana-Farber Cancer Center; Boston Medical Center and Boston University School of Medicine; Tufts Medical Center, Boston; Baystate Medical Center, Springfield; St Vincent Hospital; University of Massachusetts Medical Center and University of Massachusetts Medical School, Worcester; Shields Health Care Group, Quincy; and Lahey Hospital and...

Abstract

Because of increased treatment planning time and quality assurance, IMRT is costly. Blue Cross Blue Shield of Massachusetts and the Massachusetts Radiation Oncology Physicians Advisory Council have developed a strategy to develop standards for the appropriate use of IMRT.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology(nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.2014.001473

Reference18 articles.

1. The War on Cancer: Progress at What Price?

2. Adoption of Intensity-Modulated Radiation Therapy for Breast Cancer in the United States

3. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005)

4. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Administrative Alignment for Integrated Diagnostics Leads to Shortened Time to Diagnose and Service Optimization;Radiology;2024-07-01

2. Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy;International Journal of Radiation Oncology*Biology*Physics;2021-08

3. Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop;International Journal of Radiation Oncology*Biology*Physics;2017-03

4. The Radiation Oncology Job Market: The Economics and Policy of Workforce Regulation;International Journal of Radiation Oncology*Biology*Physics;2016-11

5. Health Care Infrastructure for Financially Sustainable Clinical Genomics;The Journal of Molecular Diagnostics;2016-09